Contact Us

Please leave a message

×

Zurich, January 19, 2018 – DKSH Business Unit Technology and Solida Biotech, a company specialized in engineering, developing, and manufacturing innovative bioprocess equipment, have signed an exclusive agreement. DKSH will provide marketing, sales and after-sales services for Solida Biotech’s full range of products in Indonesia, Korea, Malaysia, Taiwan, Thailand and Vietnam.

Solida Biotech manufactures a wide range of compact, modular and parallelly re-usable, disposable and SIP in situ sterilizable bioreactors and fermenters.  These are designed for multi-purpose microbiological and biological applications, such as CIP cleaning in place systems, sanitary process vessels, storage and preparation vessels as well as online analyzers for bioprocess monitoring and control for research, development, and production. Solida’s bioreactors and fermenters are suitable for fermentation, cell culture, stem cells, renewable technologies, algae, biomass, biofuel, hydrolysis and more.

DKSH will introduce Solida’s innovative products to the pharmaceutical and biotechnological industries, bio-food industries, cosmetic industries, R&D institutes and universities in the field of life sciences, renewable energies industries and institutions.

“Our products are leveraged in a wide range of applications including cell line development, process optimization and characterization, process development and industrial manufacturing. We believe that DKSH’s experience in the scientific instrumentation sector in Asia will help us in bringing our innovative solutions to more customers,” said Edoardo Lombardini, CEO, Solida Biotech.

“DKSH offers a one-stop-shop solution for our clients based on a well-established go-to-market strategy and an excellent marketing, sales and service team. We are well positioned and confident to grow Solida Biotech in Asia,” said Hanno Elbraechter, Head Business Unit Technology, DKSH.

About Solida Biotech
Solida Biotech is a dynamic, privately-owned company that specializes in engineering, developing, and manufacturing innovative bioprocess equipment. With a management team with over 20 years’ experience and backgrounds in the fields of fermentation, sterile processing, and automation technologies, the company was founded to meet the challenges of producing and supplying leading industrial and institutional customers with a new generation of bioreactors and fermenters for research and production, as well as analytical instruments. From the outset, Solida Biotech has invested heavily into optimizing its product line and our customers can now benefit from high-quality systems created to meet the latest pharmaceutical standards. The company has always been managed under a strict quality control regime, where all production phases, including materials and suppliers are fully traced and qualified. All Solida Biotech’s bioprocess equipment meets the latest GLP, cGMP, GAMP, FDA and SFDA standards for worldwide distribution.

About DKSH
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets. Publicly listed on the SIX Swiss Exchange since 2012, DKSH is a global company headquartered in Zurich. With 780 business locations in 36 countries – 750 of them in Asia – and 30,320 specialized staff, DKSH generated net sales of CHF 10.5 billion in 2016. DKSH was founded in 1865. With strong Swiss heritage, the company has a long tradition of doing business in and with Asia and is deeply rooted in communities and businesses across Asia Pacific.

DKSH Business Unit Technology is the leading provider of Market Expansion Services covering a broad range of capital investment goods and analytical instruments. The Business Unit offers total solutions in the areas of infrastructure, industrial materials and supplies, precision- and textile machinery, semiconductor, photovoltaic and electronics, agriculture, hospitality as well as specialized industrial applications. The service portfolio includes product sourcing, market entry consultancy, marketing, sales, application engineering and after-sales services like installations, maintenance and repairs. With 80 business locations in 18 countries and around 1,360 specialized staff, including 500 service engineers, Business Unit Technology generated net sales of CHF 385.4 million in 2016.